US equities
|
ANT
$97.17
▲+17.07%
NVDA
$145.98
▼-3.30%
AMD
$489.19
▼-7.72%
MU
$690.44
▼-2.10%
SPCX
$138.43
▼-3.53%
MSFT
$498.30
▼-1.97%
AAPL
$349.21
▼-0.92%
AMZN
$257.37
▼-3.87%
ANT
$97.17
▲+17.07%
NVDA
$145.98
▼-3.30%
AMD
$489.19
▼-7.72%
MU
$690.44
▼-2.10%
SPCX
$138.43
▼-3.53%
MSFT
$498.30
▼-1.97%
AAPL
$349.21
▼-0.92%
AMZN
$257.37
▼-3.87%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Chikungunya
Recent news which mentions Chikungunya
Read Why Valneva's Stock Gained 7% Today
March 08, 2022
Tickers
VALN
Tags
Health Care
VALN
Chikungunya
From
Benzinga
Valneva Kickstarts Phase 3 Trial Of Chikungunya Vaccine Candidate In Adolescents
February 01, 2022
Tickers
VALN
Tags
VALN
Chikungunya
Small Cap
From
Benzinga
Moderna Scraps mRNA-Based Antibody Program Targeting Chikungunya Virus
November 04, 2021
Tickers
MRNA
Tags
Briefs
Movers
General
From
Benzinga
Valneva's Chikungunya Vaccine Candidate Shows Protective Neutralizing Antibodies In Late-Stage Trial
August 05, 2021
Tickers
VALN
Tags
Briefs
General
Market News
From
Benzinga